Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aeterna Zentaris Inc T.AEZS

Alternate Symbol(s):  AEZS

Healthcare Biotechnology
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The... see more

Recent & Breaking News (TSX:AEZS)

Aeterna Zentaris Expands Promotion of APIFINY® into Florida

Business Wire August 8, 2016

Aeterna Zentaris and Rafa Laboratories Sign Exclusive License Agreement for Zoptrex™ in Israel

Business Wire August 1, 2016

Aeterna Zentaris to Announce Second Quarter 2016 Financial and Operating Results on August 9, 2016

Business Wire July 27, 2016

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  July 1, 2016

Mid-Day Market Update: Franklin Covey Slides Following Weak Results; Aeterna Zentaris Shares Surge

Benzinga.com  July 1, 2016

Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs

Benzinga.com  July 1, 2016

Aeterna Zentaris and Orient EuroPharma Co., Ltd. Sign Exclusive License Agreement for Zoptrex™ in Taiwan and Southeast Asia

Business Wire July 1, 2016

Aeterna Zentaris Announces IND Submission by Sinopharm A-Think

Business Wire June 14, 2016

Aeterna Zentaris Reconfirms Commitment to LHRH-receptor Targeting Zoptrex™ During 2016 ASCO Annual Meeting

Business Wire June 6, 2016

Aeterna Zentaris Elects Ms. Carolyn Egbert as Independent Chair of the Board

Business Wire May 23, 2016

Renesas Electronics America to Showcase IoT Design Innovation at the Internet of Things Developers Conference 2016

Business Wire May 23, 2016

Aeterna Zentaris Announces Election of Directors at 2016 Shareholders' Meeting

Business Wire May 10, 2016

Aeterna Zentaris Reports First Quarter 2016 Financial and Operating Results

Business Wire May 9, 2016

Aeterna Zentaris Acquires Exclusive U.S. Promotional Rights for APIFINY® Prostate Cancer Blood Test

Business Wire April 27, 2016

Aeterna Zentaris to Announce First Quarter 2016 Financial and Operating Results on May 9, 2016

Business Wire April 26, 2016

Aeterna Zentaris Mails Information Circular in Connection with Annual Meeting of Shareholders

Business Wire April 8, 2016

Aeterna Zentaris Announces At the Market Issuance Program

Business Wire April 1, 2016

Aeterna Zentaris Reports Fourth Quarter and Full-Year 2015 Financial and Operating Results

Business Wire March 29, 2016

Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2015 Financial and Operating Results on March 29, 2016

Business Wire March 15, 2016

Aeterna Zentaris Reports on Zoptrex(TM) Development Progress in China

Business Wire March 1, 2016